Biosimilars are highly similar versions of complex biologic drugs, approved by the FDA to be as safe and effective as the original. They offer major cost savings without compromising care for conditions like arthritis, cancer, and diabetes.
In 2025, Medicare Part D formularies are changing fast-generics and biosimilars are replacing brand-name drugs to cut costs. Know how to check your plan, handle switches, and fight denials before January 1.